Sermorelin

Resumen del Protocolo

Resumen conciso del once‑daily nightly regimen.

• Objetivo:Stimulate endogenous pituitary GH release to support physiologic IGF‑1 levels and anabolic processes.
• Programa:Daily inyecciones subcutáneas at bedtime for 3–6 months (pediatric trials ran 6–12 months; adult use is off‑label).
• Rango de dosis:200–500 µg daily (adult research range; pediatric: 30 µg/kg nightly).
• Reconstitución:3.0 mL por vial de 10 mg (~3.33 mg/mL) para medidas precisas de unidades.
• Almacenamiento:Lyophilized refrigerated; reconstituted refrigerated and used within 10–14 días.

Protocolo de Dosis

Suggested nightly titration approach for adult off‑label use.

• Inicio:200 µg nightly at bedtime; increase by ~100 µg every 1–2 semanas según tolerancia.
• Dosis Objetivo:300–500 µg nightly by Semanas 5–8 (adjust based on IGF‑1 response).
• Frecuencia:Una vez al día (subcutaneous, preferably before sleep).
• Duración del ciclo:3–6 months typical for adult research use; pediatric trials ran 6–12 months.
• Momento de aplicación:Bedtime administration leverages natural nocturnal GH pulse; rotar sitio de inyeccións systematically.

Pasos para Reconstituir

• Extraer3.0 mLde agua bacteriostática con una jeringa estéril.
• Inyectar slowly down the vial wall; gently swirl to dissolve (do not shake vigorously).
• Label with reconstitution date and refrigerate at2–8 °C (36–46 °F), protegido de la luz.
• Wipe vial stopper with alcohol before each use; use a new sterile needle and syringe for each inyectarion.

Posibles Beneficios

Observations from pediatric ensayos clínicos and adult off‑label research.